Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice

Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis

(2015) D.R. Stevens et al.   Transplant Infectious Disease

Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients

(2015) Steven Gabardi et al.   TRANSPLANTATION

A Direct and Indirect Comparison Meta-Analysis on the Efficacy of Cytomegalovirus Preventive Strategies in Solid Organ Transplant

(2014) D. F. Florescu et al.   CLINICAL INFECTIOUS DISEASES

Cytomegalovirus-Infected Human Endothelial Cells Can Stimulate Allogeneic CD4+ Memory T Cells by Releasing Antigenic Exosomes

(2014) J. D. Walker et al.   JOURNAL OF IMMUNOLOGY

Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R−): experience from the RESITRA-REIPI cohort

(2014) Y. Meije et al.   Transplant Infectious Disease

Cytomegalovirus Serology and Replication Remain Associated With Solid Organ Graft Rejection and Graft Loss in the Era of Prophylactic Treatment

(2014) Martin Stern et al.   TRANSPLANTATION

Risk Factors for Late-Onset Cytomegalovirus Infection or Disease in Kidney Transplant Recipients

(2014) Alainna J. Jamal et al.   TRANSPLANTATION

Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant Recipients

(2013) O. Manuel et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cytomegalovirus in Solid Organ Transplantation

(2013) R. R. Razonable et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation

(2013) R. R. Razonable et al.   CLINICAL MICROBIOLOGY REVIEWS

International Survey of Cytomegalovirus Management in Solid Organ Transplantation After the Publication of Consensus Guidelines

(2013) Amelia K. Le Page et al.   TRANSPLANTATION

Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation

(2013) Camille N. Kotton et al.   TRANSPLANTATION

Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy

(2012) S. F. Atabani et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial

(2012) D. J. Winston et al.   AMERICAN JOURNAL OF TRANSPLANTATION

An International Multicenter Performance Analysis of Cytomegalovirus Load Tests

(2012) H. H. Hirsch et al.   CLINICAL INFECTIOUS DISEASES

Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis

(2012) Guy Boivin et al.   JOURNAL OF CLINICAL VIROLOGY

Cytomegalovirus infection: Its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: A single-center experience

(2012) Manav Wadhawan et al.   LIVER TRANSPLANTATION

GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients

(2011) Julian Torre-Cisneros et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH

Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial

(2011) Oliver Witzke et al.   TRANSPLANTATION

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

(2010) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004

(2010) Sheri Lewis Bate et al.   CLINICAL INFECTIOUS DISEASES

Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study

(2010) J.F. Delgado et al.   Transplant Infectious Disease

Cytomegalovirus risk factors in renal transplantation with modern immunosuppression

(2010) S. Bataille et al.   Transplant Infectious Disease

Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study

(2010) Atul Humar et al.   TRANSPLANTATION

Universal Prophylaxis is Cost Effective in Cytomegalovirus Serology-Positive Kidney Transplant Patients

(2010) Fu L. Luan et al.   TRANSPLANTATION

The ‘Indirect’ Effects of Cytomegalovirus Infection

(2009) R. B. Freeman et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Interlaboratory Comparison of Cytomegalovirus Viral Load Assays

(2009) X. L. Pang et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Commutable Cytomegalovirus Calibrator Is Required to Improve the Agreement of Viral Load Values between Laboratories

(2009) A. M. Caliendo et al.   CLINICAL CHEMISTRY

Impact of Genetic Polymorphisms in Cytomegalovirus Glycoprotein B on Outcomes in Solid‐Organ Transplant Recipients with Cytomegalovirus Disease

(2009) Oriol Manuel et al.   CLINICAL INFECTIOUS DISEASES

Improvement in Long-Term Renal Graft Survival due to CMV Prophylaxis with Oral Ganciclovir: Results of a Randomized Clinical Trial

(2008) V. Kliem et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Impact of Current Transplantation Management on the Development of Cytomegalovirus Disease after Renal Transplantation

(2008) Rafael San Juan et al.   CLINICAL INFECTIOUS DISEASES